镇痛伤害指数指导镇痛对烟雾病手术患儿的效果:随机对照试验
本研究在40例接受脑硬膜动脉血管融通术的烟雾病患儿中,比较镇痛伤害指数(ANI)指导与标准镇痛对术中舒芬太尼用量及术后疼痛的影响。结果显示ANI组术中舒芬太尼消耗量更低,术后24小时内疼痛评分及恶心发生率更低。
要点
- ANI指导镇痛可降低烟雾病患儿术中舒芬太尼用量。
- ANI组术后24小时内疼痛评分更低,恶心更少。
- 需注意本研究样本量小,结论需进一步验证。
核心结论
- ANI指导的镇痛方案可减少烟雾病患儿脑硬膜动脉血管融通术中的舒芬太尼消耗量,并降低术后24小时内疼痛评分及恶心发生率。
研究设计与样本
- 前瞻性随机对照研究,在韩国首尔大学儿童医院开展,共纳入40例拟行脑硬膜动脉血管融通术的患儿。
主要发现
- ANI组术中舒芬太尼消耗量(μg kg⁻¹ h⁻¹)低于标准组(0.30 ± 0.12 对 0.39 ± 0.17;平均差 -0.09;95%CI -0.19 至 0.00;P = 0.049)。
- 术后18小时疼痛评分中位数ANI组低于标准组(1 [0 至 2] 对 3 [2 至 5];P = 0.004)。
- 术后24小时疼痛评分中位数ANI组低于标准组(1 [0 至 2] 对 3 [1 至 4];P = 0.041)。
- 术后24小时内最大疼痛评分中位数ANI组低于标准组(4 [3 至 5] 对 5 [4 至 7];P = 0.045)。
- ANI组恶心发生率低于标准组(3 [15%] 对 10 [50%],P = 0.043)。
临床怎么用
- 在烟雾病患儿行脑硬膜动脉血管融通术时,可考虑使用ANI指导术中镇痛以减少舒芬太尼用量并改善术后疼痛及恶心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The potential benefits of Analgesia Nociception Index guided intra-operative analgesia on intra-operative opioid consumption remains to be demonstrated in paediatric anaesthesia. OBJECTIVES: This study aimed to explore the effects of Analgesia Nociception Index guided analgesia on sufentanil consumption during anaesthesia and postoperative pain scores in paediatric patients with moyamoya disease. DESIGN: A prospective randomised controlled study. SETTING: Seoul National University Children's Hospital, Seoul, Republic of Korea. PATIENTS: A total of 40 children scheduled for encephaloduroarteriosynangiosis. MAIN OUTCOME MEASURES: The primary outcome was total intra-operative sufentanil consumption, and the secondary outcomes included postoperative pain scores and incidence of opioid-related adverse events. RESULTS: The Analgesia Nociception Index group showed lower intra-operative sufentanil consumption (in μg kg -1 h -1 ) compared with the Standard group (0.30 ± 0.12 and 0.39 ± 0.17, respectively; mean difference, -0.09; 95% confidence interval, -0.19 to 0.00; P = 0.049). Postoperatively, compared with the Standard group, the Analgesia Nociception Index group reported lower median pain scores at 18 and 24 h and maximum pain within 24 h (1 [0 to 2] vs. 3 [2 to 5]; P = 0.004, 1 [0 to 2] vs. 3 [1 to 4]; P = 0.041, and 4 [3 to 5] vs. 5 [4 to 7]; P = 0.045, respectively), with fewer patients experiencing nausea (3 [15%] vs. 10 [50%], P = 0.043). CONCLUSION: The Analgesia Nociception Index guided analgesic protocol can reduce intra-operative sufentanil consumption and postoperative pain within 24 h with fewer nausea symptoms in paediatric patients with moyamoya disease who undergo encephaloduroarteriosynangiosis. TRIAL REGISTRATION NUMBER: NCT05672212.
引用
- Park JB, Kang P, Ji SH, et al. Effects of goal-directed analgesia using the analgesia nociception index in children undergoing surgery for moyamoya disease: A randomised controlled trial. Eur J Anaesthesiol. 2024. PMID: 38832435. doi:10.1097/EJA.0000000000002013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。